{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:06:17Z","timestamp":1792724777790,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009447","name":"Leukemia & Lymphoma Society of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.exphem.2015.12.001","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T09:48:39Z","timestamp":1450432119000},"page":"166-171.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["CD44 promotes chemoresistance in T-ALL by increased drug efflux"],"prefix":"10.1016","volume":"44","author":[{"given":"Catherine","family":"Hoofd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Giambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.12.001_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.12.001_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.12.001_bib3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/nm.2960","article-title":"NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species","volume":"18","author":"Giambra","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.12.001_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.12.001_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2015.12.001_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2008.10.015","article-title":"CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity","volume":"29","author":"Mrass","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2015.12.001_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","article-title":"CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis","volume":"14","author":"Todaro","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2015.12.001_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-12-800092-2.00010-1","article-title":"Hyaluronan\u2013CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression","volume":"123","author":"Bourguignon","year":"2014","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.exphem.2015.12.001_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1541-7786.MCR-09-0237","article-title":"Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature","volume":"9","author":"Cain","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.exphem.2015.12.001_bib10","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Pear","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.12.001_bib11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cellsig.2004.11.017","article-title":"CD44v6 promotes proliferation by persisting activation of MAP kinases","volume":"17","author":"Marhaba","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.exphem.2015.12.001_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jlb.60.5.579","article-title":"Requirement for CD44 in proliferation and homing of hematopoietic precursor cells","volume":"60","author":"Khaldoyanidi","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2015.12.001_bib13","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V90.6.2217","article-title":"CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity","volume":"90","author":"Schmits","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.12.001_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.exphem.2015.12.001_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2011.04.043","article-title":"The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein","volume":"408","author":"Vogler","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2015.12.001_bib16","first-page":"5002","article-title":"Reversal mechanism of multidrug resistance by verapamil: Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562\/ADM cells","volume":"49","author":"Yusa","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.12.001_bib17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/mol.104.001701","article-title":"Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A","volume":"67","author":"Ejendal","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.exphem.2015.12.001_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.12.001_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: From adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.12.001_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Zoller","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.12.001_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1541-7786.MCR-09-0191","article-title":"Notch signal activates hypoxia pathway through HES1-dependent SRC\/signal transducers and activators of transcription 3 pathway","volume":"7","author":"Lee","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.exphem.2015.12.001_bib22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood-2006-06-030445","article-title":"Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia","volume":"109","author":"Cox","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.12.001_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/leu.2011.93","article-title":"Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations","volume":"25","author":"Gerby","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.12.001_bib24","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1182\/blood-2010-06-292300","article-title":"Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance","volume":"116","author":"Chiu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.12.001_bib25","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pbc.25470","article-title":"Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434","volume":"62","author":"Winter","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2015.12.001_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15007985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15007985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:13:05Z","timestamp":1654924385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15007985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0301472X15007985"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.12.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD44 promotes chemoresistance in T-ALL by increased drug efflux","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}